Catalina Capital Group, LLC Nkarta, Inc. Call Options Transaction History
Catalina Capital Group, LLC
- $241 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding NKTX
# of Institutions
119Shares Held
52.9MCall Options Held
145KPut Options Held
114K-
Boxer Capital, LLC San Diego, CA5.61MShares$34.8 Million3.15% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.19MShares$32.3 Million1.16% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.8MShares$23.6 Million0.08% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$23.4 Million12.85% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$22.2 Million2.71% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $302M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...